Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,573-7,584 of 10,612

Drug study icon

TerminatedNCT00314327

Optimizing Response in Psychosis Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 15 Years to 40 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

Behavioral study icon

Active Not RecruitingNCT04464980

Optimizing Retention, Duration and Discontinuation Strategies for Addiction Pharmacotherapy (RDD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Addiction

Behavioral study icon

CompletedNCT06194331

Optimizing Suicide prevention Strategies for Pediatric Primary Care

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Suicidality, DepressionBehavioralFrom 12 Years to 17 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Suicidality, Depression

Behavioral study icon

CompletedNCT02896400

Optimizing Tobacco Dependence Treatment in the Emergency Department

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

Active Not RecruitingNCT04176172

Optimizing Tobacco Use Treatment for PLWHA

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Abramson Cancer Center at Penn Medicine
Condition: Addiction

Behavioral study icon

CompletedNCT03533608

Optimizing Treatment Response in VA Specialized Intensive/Inpatient PTSD Programs

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Behavioral study icon

CompletedNCT03651453

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT05615948

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 89 Years

Countries: United States
Sponsor: Theresa Jacob, PhD, MPH
Condition: Depression

Drug study icon

CompletedNCT06086275

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Addiction

Drug study icon

CompletedNCT04238754

Oral Cannabidiol for Opioid Withdrawal

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Drug study icon

TerminatedNCT05073679

Oral Naltrexone In Pediatric Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 13 Years to 25 Years

Countries: United States
Sponsor: Rosemary Claire Roden
Condition: Eating disorders

Drug study icon

CompletedNCT01451736

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.